» Articles » PMID: 8480510

Colocalization of Cholinesterases with Beta Amyloid Protein in Aged and Alzheimer's Brains

Overview
Specialty Neurology
Date 1993 Jan 1
PMID 8480510
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

The colocalization of beta amyloid protein with the enzymes acetyl- and butyrylcholinesterase was assessed using immunocytochemistry for beta amyloid protein and a sensitive histochemical technique for cholinesterases. In non-demented aged and Alzheimer's disease brains, double-stained sections for cholinesterases and thioflavin-S showed that all thioflavin-S-positive plaques were also positive for cholinesterases, indicating the presence of these enzymes in all plaques with beta-pleated amyloid protein. When amyloid angiopathy was present, cholinesterases were also observed in amyloid-laden vessels walls. Comparison of series of adjacent sections alternatively stained for acetylcholinesterase, beta amyloid protein and butyrylcholinesterase, as well as by double histo-immunocytochemical staining, showed either cholinesterase in a proportion of the preamyloid diffuse plaques. These data indicate that cholinesterases are associated with the amyloid protein from very early stages, when the beta-pleated structure is being formed. Novel functions attributed to acetyl- and butyrylcholinesterase, such us their proteolytic activity either by themselves or in association with heparan sulfate proteoglycans, may play a role in the aggregation or the consolidation processes taking place at the early stages of diffuse plaque formation.

Citing Articles

Behavioral and Biochemical Effects of an Arylhydrazone Derivative of 5-Methoxyindole-2-Carboxylic Acid in a Scopolamine-Induced Model of Alzheimer's Type Dementia in Rats.

Petkova-Kirova P, Anastassova N, Minchev B, Uzunova D, Grigorova V, Tsvetanova E Molecules. 2024; 29(23).

PMID: 39683869 PMC: 11643547. DOI: 10.3390/molecules29235711.


Mannich reaction mediated derivatization of chromones and their biological evaluations as putative multipotent ligands for the treatment of Alzheimer's disease.

Kumar N, Jangid K, Kumar V, Devi B, Arora T, Mishra J RSC Med Chem. 2024; .

PMID: 39399311 PMC: 11462584. DOI: 10.1039/d4md00550c.


Protective Effect of the Novel Melatonin Analogue Containing Donepezil Fragment on Memory Impairment via MT/ERK/CREB Signaling in the Hippocampus in a Rat Model of Pinealectomy and Subsequent Aβ Infusion.

Tchekalarova J, Ivanova P, Krushovlieva D, Kortenska L, Angelova V Int J Mol Sci. 2024; 25(3).

PMID: 38339146 PMC: 10855364. DOI: 10.3390/ijms25031867.


Can Activation of Acetylcholinesterase by β-Amyloid Peptide Decrease the Effectiveness of Cholinesterase Inhibitors?.

Zueva I, Vasilieva E, Gaynanova G, Moiseenko A, Burtseva A, Boyko K Int J Mol Sci. 2023; 24(22).

PMID: 38003588 PMC: 10671303. DOI: 10.3390/ijms242216395.


The citrus flavonoid "Nobiletin" impedes STZ-induced Alzheimer's disease in a mouse model through regulating autophagy mastered by SIRT1/FoxO3a mechanism.

El-Maraghy S, Reda A, Essam R, Kortam M Inflammopharmacology. 2023; 31(5):2701-2717.

PMID: 37598127 PMC: 10518278. DOI: 10.1007/s10787-023-01292-z.


References
1.
Tagliavini F, Giaccone G, Frangione B, Bugiani O . Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals. Neurosci Lett. 1988; 93(2-3):191-6. DOI: 10.1016/0304-3940(88)90080-8. View

2.
Coria F, Castano E, Prelli F, van Duinen S, Shelanski M, Frangione B . Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis. Lab Invest. 1988; 58(4):454-8. View

3.
Khachaturian Z . Diagnosis of Alzheimer's disease. Arch Neurol. 1985; 42(11):1097-105. DOI: 10.1001/archneur.1985.04060100083029. View

4.
Nakamura S, Kawashima S, Nakano S, Tsuji T, Araki W . Subcellular distribution of acetylcholinesterase in Alzheimer's disease: abnormal localization and solubilization. J Neural Transm Suppl. 1990; 30:13-23. DOI: 10.1007/978-3-7091-3345-3_2. View

5.
Mesulam M, Geula C, Moran M . Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles. Ann Neurol. 1987; 22(6):683-91. DOI: 10.1002/ana.410220603. View